Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 122567-97-9 | MDL No. : | MFCD00871194 |
Formula : | C17H16N2O5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BKZQWZPYZIYYAQ-UONOGXRCSA-N |
M.W : | 328.32 | Pubchem ID : | 452583 |
Synonyms : |
|
Num. heavy atoms : | 24 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.24 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 86.08 |
TPSA : | 90.39 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.29 cm/s |
Log Po/w (iLOGP) : | 2.75 |
Log Po/w (XLOGP3) : | 1.42 |
Log Po/w (WLOGP) : | 0.83 |
Log Po/w (MLOGP) : | 1.4 |
Log Po/w (SILICOS-IT) : | 1.92 |
Consensus Log Po/w : | 1.66 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.81 |
Solubility : | 0.508 mg/ml ; 0.00155 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.92 |
Solubility : | 0.392 mg/ml ; 0.00119 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.54 |
Solubility : | 0.0958 mg/ml ; 0.000292 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.99 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | Stage #1: With N,N-bis(trimethylsilyl)acetamide In acetonitrile at 20℃; for 3 h; Inert atmosphere Stage #2: With trimethylsilyl trifluoromethanesulfonate In acetonitrile at -30℃; |
Was added to the reactor5-methylthymidine20-2 (0.530 g, 4.2 mmol),Compound 21-1 (0.328 g, 1.4 mmol) and40 ml of anhydrous acetonitrile, argon was added dropwise to the solution at room temperatureBis (trimethylsilyl) acetamide(2.2 mL, 8.7 mmol),After stirring for 3 hours, the temperature was lowered to -30 ° C,To the system was added trimethylsilyl trifluoromethanesulfonate (1 mL, 5.6 mmol)Stir at room temperature, TLC followed the reaction.The reaction product was added with dichloromethane,The organic layers were washed with saturated sodium bicarbonate solution, water and saturated brine, respectively,Dried, concentrated, column chromatography (MeOH: CHCl3 = 3: 100)And purified to give the title product 21-2 (yield 70percent). |
[ 3814-10-6 ]
Methyl 4-(phenylcarbamoyl)benzoate
Similarity: 0.60
[ 5395-36-8 ]
Ethyl 6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Similarity: 0.60
[ 210963-04-5 ]
4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)benzoic acid
Similarity: 0.59
[ 53681-51-9 ]
6-Amino-1-benzyl-3-methylpyrimidine-2,4(1H,3H)-dione
Similarity: 0.58
[ 446292-08-6 ]
(S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione
Similarity: 0.58
[ 174074-88-5 ]
Methyl 2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylate
Similarity: 0.72
[ 917081-58-4 ]
Di-tert-butyl 5-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate
Similarity: 0.69
[ 354587-63-6 ]
1-tert-Butyl 6-methyl 1H-indole-1,6-dicarboxylate
Similarity: 0.63
[ 85614-89-7 ]
Ethyl 5-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate
Similarity: 0.63
[ 337909-10-1 ]
Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate
Similarity: 0.62
[ 174074-88-5 ]
Methyl 2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylate
Similarity: 0.72
[ 354587-63-6 ]
1-tert-Butyl 6-methyl 1H-indole-1,6-dicarboxylate
Similarity: 0.63
[ 85614-89-7 ]
Ethyl 5-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate
Similarity: 0.63
[ 337909-10-1 ]
Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate
Similarity: 0.62
[ 3814-10-6 ]
Methyl 4-(phenylcarbamoyl)benzoate
Similarity: 0.60
[ 917081-58-4 ]
Di-tert-butyl 5-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate
Similarity: 0.69
[ 5395-36-8 ]
Ethyl 6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Similarity: 0.60
[ 42821-92-1 ]
Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Similarity: 0.60
[ 53681-51-9 ]
6-Amino-1-benzyl-3-methylpyrimidine-2,4(1H,3H)-dione
Similarity: 0.58
[ 20924-05-4 ]
2-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid
Similarity: 0.58